Stocks making the biggest moves after hours: Intel, Mattel, Gilead Sciences & more

Finance

A visitor at Intel’s Artificial Intelligence (AI) Day walks past a signboard during the event in Bangalore, India

Manjunath Kiran | Getty

Check out the companies making headlines after hours Thursday:

Intel — Intel shares dropped 10% after the bell on the back of mixed results for the company’s fiscal third quarter. The chip maker reported adjusted earnings per share of $1.11, in line with a Refinitiv estimate. Intel’s revenue for the quarter was slightly above expectations. However, sales for the company’s Data Center Group came in at $5.91 billion, below a FactSet estimate of $6.21 billion.

Mattel — Shares of the toy maker jumped about 8% after the company posted much better-than-expected results for the previous quarter. Mattel reported earnings per share of 95 cents on revenue of $1.63 billion. Analysts expected a profit of 39 cents per share on revenue of $1.46 billion, according to Refinitiv. The company’s results were driven in part by strong sales from its Dolls division.

Gilead Sciences — Gilead popped more than 3% after the Food and Drug Administration approved the use of the company’s remdesivir drug as a treatment against the coronavirus.

Robert Half International — Shares of the human resources company ticked higher by 0.3% following the release of stronger-than-forecast quarterly earnings. Robert Half reported earnings per share of 67 cents, topping a FactSet estimate of 58 cents per share. “We are very pleased that third-quarter and early October results reflect consistent weekly and monthly sequential gains across our divisions,” CEO M. Keith Waddell said in a statement.

Seagate Technology — The data storage company saw its stock fall more than 5% following the release of mixed results for the previous quarter. Seagate posted earnings of 93 cents per share, topping a Refinitiv estimate. However, the company’s revenue of $2.31 billion was just shy of analyst expectations.

Articles You May Like

Exxon earnings beat, increases fourth-quarter dividend
Linde falls after its guidance fails to wow the market. We’ve seen this movie before
Novo Nordisk’s Ozempic and Wegovy now available in the U.S. after shortages, FDA says
Pending home sales took an unexpected leap higher last month, but rates have climbed back up
Starbucks will discontinue Oleato olive oil drinks at U.S. cafes in early November

Leave a Reply

Your email address will not be published. Required fields are marked *